Todd N. Smith
Director · Latigo Biotherapeutics, Inc.
Individual
- 2026
- Aug 11, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Todd N. Smith files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- James B. Tananbaum - $2.52M in LTGO purchases and sales in the last 12 months
- Foresite Capital Management V, LLC - $2.52M in LTGO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Todd N. Smith?
Todd N. Smith is a corporate insider, tracked as Director of Latigo Biotherapeutics, Inc. (LTGO). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Todd N. Smith submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.